Combined regimen of cisplatin, doxorubicin, and alpha-2b interferon in the treatment of advanced malignant pleural mesothelioma: a Phase II multicenter trial of the Italian Group on Rare Tumors (GITR) and the Italian Lung Cancer Task Force (FONICAP) (Q33338541)
scientific article
Language:
(P31) (Q13442814)
(P304) 650-656
(P407) (Q1860)
(P433) 3
(P478) 92
(P577) Wednesday, August 1, 2001
(P921) (Q42824440)
(Q6934595)
(Q38)
(Q18557602)
(Q18936)
(Q19000969)
(Q412415)
(P1433) (Q326041)
(P1476) "Combined regimen of cisplatin, doxorubicin, and alpha-2b interferon in the treatment of advanced malignant pleural mesothelioma: a Phase II multicenter trial of the Italian Group on Rare Tumors (GITR) and the Italian Lung Cancer Task Force (FONICAP)" (language: en)
(P2093) H S Parra
L Tixi
F Latteri
S Bretti
M Alloisio
A Gravina
R Lionetto
P Bruzzi
C Dani
R Rosso
M Cosso
L Balzarini
A Santoro
A Ardizzoni
(P2860) (Q43751848)
(Q40891630)
(Q38563914)
(Q41702837)
(Q34295028)
(Q29620070)
(Q46412217)
(Q25938997)
(Q36677129)
(Q40520366)
(Q54577322)
(Q34344877)
(Q34371245)
(Q34747175)
(Q33495644)
(Q40698568)
(Q41640244)
(Q45755851)
(Q33329809)
(Q70176734)
(Q73335125)
(Q54589008)
(Q70615554)
(Q67993403)
(Q71046770)
(Q67470911)
(Q72107553)
(Q72547124)
(Q53958476)
(Q74202142)
(Q74661222)
(Q78147639)
other details